My first two thoughts after reading TMFDaddyO's description of BREL:1) Would they be badly hurt by their customers' cashflow problems? People worry about biotech "cash burn". Is BREL the little company that gets trod on when (and if, of course) the proverbial hits the fan.2) Why would SBC (sexy biotech company) use BREL? Sure, science is full of drudge work. That's what PhD students are for. I bet it is much cheaper to give a studentship than to outsource. Secondly, discoveries don't happen when you expect them to. By outsourcing you lose part of the ability to make discoveries.Sorry if this is terse and sounds negative, but due to some computer issues it is the third time I've written this post. I'm pointing out some issues that I would want to be satisfied upon.Hamish Rose
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Ma